Publication:
Association of TRPM Channel Gene Polymorphisms with Systemic Sclerosis

dc.contributor.authorsOztuzcu, Serdar; Onat, Ahmet M.; Pehlivan, Yavuz; Alibaz-Oner, Fatma; Donmez, Salim; Cetin, Gozde Y.; Yolbas, Servet; Bozgeyik, Ibrahim; Yilmaz, Neslihan; Ozgen, Metin; Cagatay, Yonca; Kisacik, Bunyamin; Koca, Suleyman S.; Pamuk, Omer Nuri; Sayarlioglu, Mehmet; Direskeneli, Haner; Demiryurek, Abdullah T.
dc.date.accessioned2022-03-12T20:26:57Z
dc.date.accessioned2026-01-10T21:37:32Z
dc.date.available2022-03-12T20:26:57Z
dc.date.issued2015
dc.description.abstractBackground/Aim: Systemic sclerosis (SSc) is an inflammatory disease characterized by vascular abnormalities and fibrosis. The aim of the present study was to investigate the possible role of transient receptor potential melastatin (TRPM) channel genes in the susceptibility and phenotype expression of SSc. Materials and Methods: A total of 339 patients with SSc and 302 healthy controls were studied. Genomic DNA was extracted from leukocytes of the peripheral blood, and 25 single nucleotide polymorphisms in the TRPM channel genes were analyzed by the BioMark HD dynamic array system. Results: There were marked increases in the CC genotype (94.7% vs 81.8%, p<0.0001) and C allele frequencies (97.0% vs. 90.1%, p<0.0001) in the TRPM3 rs1328142, and TT genotype (19.0% vs. 7.8%, p=0.0002) in TRPM5 rs34551253 (Ala456Thr) polymorphism in SSc patients when compared to controls. TRPM3 gene rs1328142 polymorphism was also markedly associated with disease phenotype. However, no associations with the other 23 polymorphisms studied were found. Conclusion: This is the first study to examine the involvement of TRPM channel gene variations on the risk of SSc incidence. Our results suggest roles of TRPM3 and TRPM5 gene variants in the susceptibility to or clinical expression of SSc in the Turkish population.
dc.identifier.doidoiWOS:000365993400016
dc.identifier.eissn1791-7549
dc.identifier.issn0258-851X
dc.identifier.pubmed26546534
dc.identifier.urihttps://hdl.handle.net/11424/233595
dc.identifier.wosWOS:000365993400016
dc.language.isoeng
dc.publisherINT INST ANTICANCER RESEARCH
dc.relation.ispartofIN VIVO
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCation channels
dc.subjecthaplotype
dc.subjectpolymorphism
dc.subjectscleroderma
dc.subjectsystemic sclerosis
dc.subjecttransient receptor potential melastatin
dc.subjectPULMONARY ARTERIAL-HYPERTENSION
dc.subjectSMOOTH-MUSCLE-CELLS
dc.subjectOXIDATIVE STRESS
dc.subjectDISEASE-ACTIVITY
dc.subjectSCLERODERMA
dc.subjectCLASSIFICATION
dc.subjectIDENTIFICATION
dc.subjectPATHOGENESIS
dc.subjectCRITERIA
dc.titleAssociation of TRPM Channel Gene Polymorphisms with Systemic Sclerosis
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage770
oaire.citation.issue6
oaire.citation.startPage763
oaire.citation.titleIN VIVO
oaire.citation.volume29

Files